Epidemiology and surveillance of human (neuro)cysticercosis in Europe

• Main Author: Abraham, Annette
• Publication Date: 2020
• Other Authors: Schmidt, Veronika, Kaminski, Miriam, Stelzle, Dominik, De Meijere, Robert, Bustos, Javier, Soumyaranjan Sahu, Priyadarshi, Hugo Garcia, Hector, Bobić, Branko, Cretu, Carmen, Chiodini, Peter, Deksne, Gunita, Dermauw, Veronique, Devleesschauwer, Brecht, Dorny, Pierre, Fonseca, Ana, Gabriël, Sarah, Ángeles Gómez Morales, Maria, Kucsera, István, Laranjo-González, Minerva, Trevisan, Chiara, Vilhena, Manuela, Walker, Naomi F, Zammarchi, Lorenzo, Sylvia Winkler, Andrea
• Format: Article
• Language: eng
• Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
• Download full: http://hdl.handle.net/10362/149269
• topic: Europe; epidemiology; neurocysticercosis; Parasitology; Public Health, Environmental and Occupational Health; Infectious Diseases; SDG 3 - Good Health and Well-being

OBJECTIVES: To report on relevant national surveillance systems of (N)CC and taeniasis (the infection with the adult tapeworm) in the European Union/European Economic Area, and to assess the magnitude of (N)CC occurrence by retrieving information on cases for the period 2000-2016. METHODS: (N)CC cases were retrieved via national reporting systems, a systematic literature search, contact with clinicians, and a search for relevant "International Statistical Classification of Diseases and Related Health Problems" (ICD)-based data. RESULTS: Mandatory notification systems for (N)CC were found in Hungary, Iceland and Poland. Ten cases were reported in Poland and none in Hungary and Iceland. Through the systematic literature review and information given by clinicians, 263 individual and 721 aggregated (N)CC cases from 19 European countries were identified. ICD-based data were obtained from five countries. From 2000 to 2016, a total of 3,489 cases (N)CC cases were coded: 832 in Italy, 8 in Latvia, 357 in Portugal, 2116 in Spain and 176 in Sweden. CONCLUSION: Despite being classified as a possible eradicable disease, (N)CC is still diagnosed across Europe, yet its true extent and impact remain unclear.